| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $669.1M | +10.1% |
| Cost of Revenue | $114.8M | +2.9% |
| Gross Profit | $554.4M | +11.7% |
| R&D Expense | $117.3M | +4.9% |
| SG&A Expense | $71.6M | +4.2% |
| Operating Income | $222.0M | +18.6% |
| Pre-tax Income | $246.8M | +17.6% |
| Income Tax | $48.5M | +34.2% |
| Net Income | $198.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $250.3M | +7.8% |
| Accounts Receivable | $171.0M | +3.9% |
| Current Assets | $657.6M | +12.3% |
| Total Assets | $1.10B | +12.5% |
| Current Liabilities | $467.3M | +9.1% |
| Total Liabilities | $533.9M | +7.6% |
| Stockholders' Equity | $561.2M | +17.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $309.4M | +26.8% |
| Capital Expenditures | $5.0M | -59.5% |
| Investing Cash Flow | -$105.9M | -48.3% |
| Financing Cash Flow | -$185.4M | -27.3% |
| Free Cash Flow | $304.4M | +31.3% |
| +14.2% |
| EPS (Basic) | $5.49 | +16.3% |
| EPS (Diluted) | $5.44 | +17.0% |